Blood Glucose Device-Europe Market Status and Trend Report 2013-2023
Report Summary
Blood Glucose Device-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Device industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Blood Glucose Device 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Device in Europe, with company and product introduction, position in the Blood Glucose Device market
Market status and development trend of Blood Glucose Device by types and applications
Cost and profit status of Blood Glucose Device, and marketing status
Market growth drivers and challenges
The report segments the Europe Blood Glucose Device market as:
Europe Blood Glucose Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Blood Glucose Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
Europe Blood Glucose Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Diagnostics
Home Settings
Others
Europe Blood Glucose Device Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Device Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Blood Glucose Device-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Device industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Blood Glucose Device 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Device in Europe, with company and product introduction, position in the Blood Glucose Device market
Market status and development trend of Blood Glucose Device by types and applications
Cost and profit status of Blood Glucose Device, and marketing status
Market growth drivers and challenges
The report segments the Europe Blood Glucose Device market as:
Europe Blood Glucose Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Blood Glucose Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
Europe Blood Glucose Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Diagnostics
Home Settings
Others
Europe Blood Glucose Device Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Device Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BLOOD GLUCOSE DEVICE
1.1 Definition of Blood Glucose Device in This Report
1.2 Commercial Types of Blood Glucose Device
1.2.1 Blood Glucose Monitors
1.2.2 Glucose Monitoring Strips
1.2.3 Lancets
1.3 Downstream Application of Blood Glucose Device
1.3.1 Hospitals
1.3.2 Diagnostics
1.3.3 Home Settings
1.3.4 Others
1.4 Development History of Blood Glucose Device
1.5 Market Status and Trend of Blood Glucose Device 2013-2023
1.5.1 Europe Blood Glucose Device Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Device Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Device in Europe 2013-2017
2.2 Consumption Market of Blood Glucose Device in Europe by Regions
2.2.1 Consumption Volume of Blood Glucose Device in Europe by Regions
2.2.2 Revenue of Blood Glucose Device in Europe by Regions
2.3 Market Analysis of Blood Glucose Device in Europe by Regions
2.3.1 Market Analysis of Blood Glucose Device in Germany 2013-2017
2.3.2 Market Analysis of Blood Glucose Device in United Kingdom 2013-2017
2.3.3 Market Analysis of Blood Glucose Device in France 2013-2017
2.3.4 Market Analysis of Blood Glucose Device in Italy 2013-2017
2.3.5 Market Analysis of Blood Glucose Device in Spain 2013-2017
2.3.6 Market Analysis of Blood Glucose Device in Benelux 2013-2017
2.3.7 Market Analysis of Blood Glucose Device in Russia 2013-2017
2.4 Market Development Forecast of Blood Glucose Device in Europe 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Device in Europe 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Device by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Device in Europe by Types
3.1.2 Revenue of Blood Glucose Device in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Blood Glucose Device in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Device in Europe by Downstream Industry
4.2 Demand Volume of Blood Glucose Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Device by Downstream Industry in Germany
4.2.2 Demand Volume of Blood Glucose Device by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Blood Glucose Device by Downstream Industry in France
4.2.4 Demand Volume of Blood Glucose Device by Downstream Industry in Italy
4.2.5 Demand Volume of Blood Glucose Device by Downstream Industry in Spain
4.2.6 Demand Volume of Blood Glucose Device by Downstream Industry in Benelux
4.2.7 Demand Volume of Blood Glucose Device by Downstream Industry in Russia
4.3 Market Forecast of Blood Glucose Device in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE DEVICE
5.1 Europe Economy Situation and Trend Overview
5.2 Blood Glucose Device Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Blood Glucose Device in Europe by Major Players
6.2 Revenue of Blood Glucose Device in Europe by Major Players
6.3 Basic Information of Blood Glucose Device by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Device Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories (U.S.)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Device Product
7.1.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Abbott Laboratories (U.S.)
7.2 ARKRAY (Japan)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Device Product
7.2.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.3 Dexcom (U.S.)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Device Product
7.3.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Dexcom (U.S.)
7.4 F.Hoffmann-La Roche Ltd (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Device Product
7.4.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd (Switzerland)
7.5 Johnson & Johnson (U.S.)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Device Product
7.5.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
7.6 Medtronic (U.S.)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Device Product
7.6.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.7 Nipro Diagnostics (U.S.)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Device Product
7.7.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Nipro Diagnostics (U.S.)
7.8 Terumo Medical Corporation (U.S.)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Device Product
7.8.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Terumo Medical Corporation (U.S.)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE DEVICE
8.1 Industry Chain of Blood Glucose Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE DEVICE
9.1 Cost Structure Analysis of Blood Glucose Device
9.2 Raw Materials Cost Analysis of Blood Glucose Device
9.3 Labor Cost Analysis of Blood Glucose Device
9.4 Manufacturing Expenses Analysis of Blood Glucose Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Blood Glucose Device in This Report
1.2 Commercial Types of Blood Glucose Device
1.2.1 Blood Glucose Monitors
1.2.2 Glucose Monitoring Strips
1.2.3 Lancets
1.3 Downstream Application of Blood Glucose Device
1.3.1 Hospitals
1.3.2 Diagnostics
1.3.3 Home Settings
1.3.4 Others
1.4 Development History of Blood Glucose Device
1.5 Market Status and Trend of Blood Glucose Device 2013-2023
1.5.1 Europe Blood Glucose Device Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Device Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Device in Europe 2013-2017
2.2 Consumption Market of Blood Glucose Device in Europe by Regions
2.2.1 Consumption Volume of Blood Glucose Device in Europe by Regions
2.2.2 Revenue of Blood Glucose Device in Europe by Regions
2.3 Market Analysis of Blood Glucose Device in Europe by Regions
2.3.1 Market Analysis of Blood Glucose Device in Germany 2013-2017
2.3.2 Market Analysis of Blood Glucose Device in United Kingdom 2013-2017
2.3.3 Market Analysis of Blood Glucose Device in France 2013-2017
2.3.4 Market Analysis of Blood Glucose Device in Italy 2013-2017
2.3.5 Market Analysis of Blood Glucose Device in Spain 2013-2017
2.3.6 Market Analysis of Blood Glucose Device in Benelux 2013-2017
2.3.7 Market Analysis of Blood Glucose Device in Russia 2013-2017
2.4 Market Development Forecast of Blood Glucose Device in Europe 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Device in Europe 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Device by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Device in Europe by Types
3.1.2 Revenue of Blood Glucose Device in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Blood Glucose Device in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Device in Europe by Downstream Industry
4.2 Demand Volume of Blood Glucose Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Device by Downstream Industry in Germany
4.2.2 Demand Volume of Blood Glucose Device by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Blood Glucose Device by Downstream Industry in France
4.2.4 Demand Volume of Blood Glucose Device by Downstream Industry in Italy
4.2.5 Demand Volume of Blood Glucose Device by Downstream Industry in Spain
4.2.6 Demand Volume of Blood Glucose Device by Downstream Industry in Benelux
4.2.7 Demand Volume of Blood Glucose Device by Downstream Industry in Russia
4.3 Market Forecast of Blood Glucose Device in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE DEVICE
5.1 Europe Economy Situation and Trend Overview
5.2 Blood Glucose Device Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Blood Glucose Device in Europe by Major Players
6.2 Revenue of Blood Glucose Device in Europe by Major Players
6.3 Basic Information of Blood Glucose Device by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Device Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories (U.S.)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Device Product
7.1.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Abbott Laboratories (U.S.)
7.2 ARKRAY (Japan)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Device Product
7.2.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.3 Dexcom (U.S.)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Device Product
7.3.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Dexcom (U.S.)
7.4 F.Hoffmann-La Roche Ltd (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Device Product
7.4.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd (Switzerland)
7.5 Johnson & Johnson (U.S.)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Device Product
7.5.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
7.6 Medtronic (U.S.)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Device Product
7.6.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.7 Nipro Diagnostics (U.S.)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Device Product
7.7.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Nipro Diagnostics (U.S.)
7.8 Terumo Medical Corporation (U.S.)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Device Product
7.8.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Terumo Medical Corporation (U.S.)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE DEVICE
8.1 Industry Chain of Blood Glucose Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE DEVICE
9.1 Cost Structure Analysis of Blood Glucose Device
9.2 Raw Materials Cost Analysis of Blood Glucose Device
9.3 Labor Cost Analysis of Blood Glucose Device
9.4 Manufacturing Expenses Analysis of Blood Glucose Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
